2012
DOI: 10.1111/j.1464-5491.2012.03574.x
|View full text |Cite
|
Sign up to set email alerts
|

Targeted treatment of invasive fungal infections accelerates healing of foot wounds in patients with Type 2 diabetes

Abstract: Fluconazole plus standard care was superior to standard care alone in accelerating wound reduction among patients with diabetes with deep-seated fungal infections in diabetic foot wounds. Those in the treatment group who did heal, healed more quickly (P ≤ 0.022), but overall healing was not different.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
21
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(21 citation statements)
references
References 27 publications
0
21
0
Order By: Relevance
“…The presence of pathogenic fungi in wounds is correlated to poorer wound healing outcomes and can complicate treatment [26][27][28]. A major component of the chronic wound microbiome is community stability, or the lack of, as being a key factor for predicting wound outcomes [6,14].…”
Section: Discussionmentioning
confidence: 99%
“…The presence of pathogenic fungi in wounds is correlated to poorer wound healing outcomes and can complicate treatment [26][27][28]. A major component of the chronic wound microbiome is community stability, or the lack of, as being a key factor for predicting wound outcomes [6,14].…”
Section: Discussionmentioning
confidence: 99%
“…Fluconazole, an antifungal drug, has been shown to significantly reduce the mean healing time of DFUs when compared to the standard of care in a randomized control study. 42 More recently, it was demonstrated that treatment of a tripartite bacterial-fungal biofilm with antibiotics alone resulted in a threefold increase of viable fungal cells, whereas only a combination treatment with antibiotics (ciprofloxacin and flucloxacillin) and fluconazole resulted in decreased viable cells of both bacteria and fungi. 40 Current literature, while limited, suggest that wound care strategies could benefit from inclusion of antifungal drugs such as fluconazole, amphotericin B, or caspofungin 43 concurrent with antibacterial therapy, or application of a broad-spectrum topical antimicrobial that targets both.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, fungal infection in DFUs is underrecognized, although recently some studies have begun to shed light on the significant involvement of the wound mycobiome (9). While antifungal treatments have been shown to improve DFU outcome, they are only used routinely to treat superficial fungal infections in diabetics, such as onychomycosis (10,11). Therefore, it is not a great leap to suspect fungal components as a key contributor to pathogenic DFU biofilms.…”
mentioning
confidence: 99%